
Dennis J. Parad
Examiner (ID: 7642)
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612 |
| Total Applications | 405 |
| Issued Applications | 162 |
| Pending Applications | 1 |
| Abandoned Applications | 240 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16229294
[patent_doc_number] => 10736823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-11
[patent_title] => Biotechnologically-produced cellulose-containing article for dermatological use
[patent_app_type] => utility
[patent_app_number] => 15/779312
[patent_app_country] => US
[patent_app_date] => 2016-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 15912
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779312
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/779312 | Biotechnologically-produced cellulose-containing article for dermatological use | Sep 26, 2016 | Issued |
Array
(
[id] => 11647725
[patent_doc_number] => 20170143624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-25
[patent_title] => 'Monovalent Metal Cation Dry Powders For Inhalation'
[patent_app_type] => utility
[patent_app_number] => 15/277062
[patent_app_country] => US
[patent_app_date] => 2016-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 41992
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15277062
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/277062 | Monovalent metal cation dry powders for inhalation | Sep 26, 2016 | Issued |
Array
(
[id] => 13383559
[patent_doc_number] => 20180243321
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => COMPOSITION AND MEDICAL DEVICE COMPRISING ACETYLSALICYLIC ACID FOR THE TREATMENT OF HUMAN PAPILLOMA VIRUS SKIN INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 15/756724
[patent_app_country] => US
[patent_app_date] => 2016-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15756724
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/756724 | Composition and medical device comprising acetylsalicylic acid for the treatment of human papilloma virus skin infections | Sep 4, 2016 | Issued |
Array
(
[id] => 13368741
[patent_doc_number] => 20180235911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => STABLE PHARMACEUTICAL COMPOSITION OF ALOGLIPTIN AND METFORMIN FIXED DOSE COMBINATION
[patent_app_type] => utility
[patent_app_number] => 15/753691
[patent_app_country] => US
[patent_app_date] => 2016-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753691
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/753691 | STABLE PHARMACEUTICAL COMPOSITION OF ALOGLIPTIN AND METFORMIN FIXED DOSE COMBINATION | Aug 19, 2016 | Abandoned |
Array
(
[id] => 13383297
[patent_doc_number] => 20180243190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => ACTIVATORS OF NRF2-DEPENDENT PHOTOPROTECTION AND RELATED USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/753514
[patent_app_country] => US
[patent_app_date] => 2016-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753514
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/753514 | ACTIVATORS OF NRF2-DEPENDENT PHOTOPROTECTION AND RELATED USES THEREOF | Aug 16, 2016 | Abandoned |
Array
(
[id] => 16058397
[patent_doc_number] => 10688121
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Granular composition for oral administration
[patent_app_type] => utility
[patent_app_number] => 15/748235
[patent_app_country] => US
[patent_app_date] => 2016-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2457
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15748235
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/748235 | Granular composition for oral administration | Jul 27, 2016 | Issued |
Array
(
[id] => 16244766
[patent_doc_number] => 10744090
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-08-18
[patent_title] => Multiphasic compositions
[patent_app_type] => utility
[patent_app_number] => 15/739575
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 23871
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15739575
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/739575 | Multiphasic compositions | Jun 29, 2016 | Issued |
Array
(
[id] => 11670153
[patent_doc_number] => 20170158872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'METHODS FOR IMPARTING ANTI-MICROBIAL, MICROBICIDAL PROPERTIES TO FABRICS, YARNS AND FILAMENTS, AND FABRICS, YARNS AND FILAMENTS EMBODYING SUCH PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 15/186067
[patent_app_country] => US
[patent_app_date] => 2016-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14298
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15186067
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/186067 | METHODS FOR IMPARTING ANTI-MICROBIAL, MICROBICIDAL PROPERTIES TO FABRICS, YARNS AND FILAMENTS, AND FABRICS, YARNS AND FILAMENTS EMBODYING SUCH PROPERTIES | Jun 16, 2016 | Abandoned |
Array
(
[id] => 11667598
[patent_doc_number] => 20170156317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'METHODS AND APPARATUS FOR PASSIVE REDUCTION OF NOSOCOMIAL INFECTIONS IN CLINICAL SETTINGS, AND FABRICS, YARNS, AND FILAMENTS FOR USE IN CONNECTION THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 15/186221
[patent_app_country] => US
[patent_app_date] => 2016-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6449
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15186221
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/186221 | METHODS AND APPARATUS FOR PASSIVE REDUCTION OF NOSOCOMIAL INFECTIONS IN CLINICAL SETTINGS, AND FABRICS, YARNS, AND FILAMENTS FOR USE IN CONNECTION THEREWITH | Jun 16, 2016 | Abandoned |
Array
(
[id] => 12765997
[patent_doc_number] => 20180147167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => METHODS AND COMPOSITIONS TO MODULATE THE GUT MICROBIOTA AND TO MANAGE WEIGHT
[patent_app_type] => utility
[patent_app_number] => 15/575942
[patent_app_country] => US
[patent_app_date] => 2016-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -49
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15575942
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/575942 | Methods and compositions to modulate the gut microbiota and to manage weight | May 30, 2016 | Issued |
Array
(
[id] => 13326155
[patent_doc_number] => 20180214615
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => POLYETHERIMIDE COMPOSITIONS FOR IMPLANTABLE MEDICAL DEVICES AND HEADER THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/574424
[patent_app_country] => US
[patent_app_date] => 2016-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15574424
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/574424 | POLYETHERIMIDE COMPOSITIONS FOR IMPLANTABLE MEDICAL DEVICES AND HEADER THEREOF | May 18, 2016 | Abandoned |
Array
(
[id] => 11031511
[patent_doc_number] => 20160228467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'PEG OR PEG BLOCK COPOLYMER FOR TREATING COLORECTAL CANCER'
[patent_app_type] => utility
[patent_app_number] => 15/134410
[patent_app_country] => US
[patent_app_date] => 2016-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13172
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15134410
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/134410 | PEG OR PEG BLOCK COPOLYMER FOR TREATING COLORECTAL CANCER | Apr 20, 2016 | Abandoned |
Array
(
[id] => 11031431
[patent_doc_number] => 20160228386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'Pharmaceutical Formulation'
[patent_app_type] => utility
[patent_app_number] => 15/133062
[patent_app_country] => US
[patent_app_date] => 2016-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3121
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15133062
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/133062 | Pharmaceutical Formulation | Apr 18, 2016 | Abandoned |
Array
(
[id] => 16025777
[patent_doc_number] => 10675288
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Natural combination hormone replacement formulations and therapies
[patent_app_type] => utility
[patent_app_number] => 15/090493
[patent_app_country] => US
[patent_app_date] => 2016-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11524
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15090493
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/090493 | Natural combination hormone replacement formulations and therapies | Apr 3, 2016 | Issued |
Array
(
[id] => 11090564
[patent_doc_number] => 20160287532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-06
[patent_title] => 'CURCUMIN FOR TREATING INTERVERTEBRAL DISC DISEASE'
[patent_app_type] => utility
[patent_app_number] => 15/082708
[patent_app_country] => US
[patent_app_date] => 2016-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10476
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15082708
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/082708 | CURCUMIN FOR TREATING INTERVERTEBRAL DISC DISEASE | Mar 27, 2016 | Abandoned |
Array
(
[id] => 11038768
[patent_doc_number] => 20160235725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'TREATMENT FOR CHEMOTHERAPY-INDUCED COGNITIVE IMPAIRMENT'
[patent_app_type] => utility
[patent_app_number] => 15/012090
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6924
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15012090
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/012090 | Treatment for chemotherapy-induced cognitive impairment | Jan 31, 2016 | Issued |
Array
(
[id] => 10774645
[patent_doc_number] => 20160120802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-05
[patent_title] => 'ORALLY-DISINTEGRATING OSELTAMIVIR TABLET AND METHOD FOR PREPARING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/992040
[patent_app_country] => US
[patent_app_date] => 2016-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7668
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14992040
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/992040 | ORALLY-DISINTEGRATING OSELTAMIVIR TABLET AND METHOD FOR PREPARING THE SAME | Jan 10, 2016 | Abandoned |
Array
(
[id] => 11002402
[patent_doc_number] => 20160199351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING FUNGAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 14/990594
[patent_app_country] => US
[patent_app_date] => 2016-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8036
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14990594
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/990594 | COMPOSITIONS AND METHODS FOR INHIBITING FUNGAL INFECTIONS | Jan 6, 2016 | Abandoned |
Array
(
[id] => 10996435
[patent_doc_number] => 20160193381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'HEMOSTATIC PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 14/988522
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6427
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14988522
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/988522 | HEMOSTATIC PRODUCTS | Jan 4, 2016 | Abandoned |
Array
(
[id] => 10987385
[patent_doc_number] => 20160184330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-30
[patent_title] => 'Suppression of Cytokine Release and Cytokine Storm'
[patent_app_type] => utility
[patent_app_number] => 14/983844
[patent_app_country] => US
[patent_app_date] => 2015-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23307
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14983844
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/983844 | Suppression of cytokine release and cytokine storm | Dec 29, 2015 | Issued |